Skip to main content
Top
Published in: Indian Journal of Surgical Oncology 1/2019

01-03-2019 | Case Report

Endometrial Stromal Sarcoma: Case Series with Emphasis on Gross Features

Authors: Gunjan Mangla, Preeti Diwaker, Priyanka Gogoi

Published in: Indian Journal of Surgical Oncology | Issue 1/2019

Login to get access

Excerpt

Endometrial stromal sarcomas (ESS) constitute around 10% of uterine sarcomas, but only 0.2% of all uterine malignancies. ESS usually present in the peri-menopausal age group, as compared to other uterine malignancies which are more common in postmenopausal women [1]. ESS are often clinically misdiagnosed as benign entities like uterine leiomyomas and are usually diagnosed postoperatively, after a histopathological examination of a hysterectomy or polypectomy specimen [2]. This calls for a repeat surgery for definitive management. …
Literature
2.
go back to reference Ashraf-Ganjoei T, Behtash N, Shariat M, Mosavi A (2006) Low grade endometrial stromal sarcoma of uterine corpus, a clinico-pathological and survey study in 14 cases. World J Surg Oncol 4:50CrossRefPubMedPubMedCentral Ashraf-Ganjoei T, Behtash N, Shariat M, Mosavi A (2006) Low grade endometrial stromal sarcoma of uterine corpus, a clinico-pathological and survey study in 14 cases. World J Surg Oncol 4:50CrossRefPubMedPubMedCentral
3.
go back to reference Kruse AJ, Croce S, Kruitwagen RF, Riedl RG, Slangen BF, Van Gorp T, Van de Vijver KK (2014) Aggressive behavior and poor prognosis of endometrial stromal sarcomas with YWHAE-FAM22 rearrangement indicate the clinical importance to recognize this subset. Int J Gynecol Cancer 24(9):1616–1622CrossRefPubMed Kruse AJ, Croce S, Kruitwagen RF, Riedl RG, Slangen BF, Van Gorp T, Van de Vijver KK (2014) Aggressive behavior and poor prognosis of endometrial stromal sarcomas with YWHAE-FAM22 rearrangement indicate the clinical importance to recognize this subset. Int J Gynecol Cancer 24(9):1616–1622CrossRefPubMed
4.
go back to reference Ali RH, Rouzbahman M (2015) Endometrial stromal tumours revisited: an update based on the 2014 WHO classification. J Clin Pathol 68:325–332CrossRefPubMed Ali RH, Rouzbahman M (2015) Endometrial stromal tumours revisited: an update based on the 2014 WHO classification. J Clin Pathol 68:325–332CrossRefPubMed
5.
go back to reference Masand RP, Euscher ED, Deavers MT, Malpica A (2013) Endometrioid stromal sarcoma: a clinicopathologic study of 63 cases. Am J Surg Pathol 37(11):1635–1647CrossRefPubMed Masand RP, Euscher ED, Deavers MT, Malpica A (2013) Endometrioid stromal sarcoma: a clinicopathologic study of 63 cases. Am J Surg Pathol 37(11):1635–1647CrossRefPubMed
6.
go back to reference Olivia E, Egger JF, Young RH (2014) Primary endometrioid stromal sarcoma of the ovary: a clinicopathologic study of 27 cases with morphologic and behavioural features similar to those of uterine low grade endometrial stromal sarcoma. Am J Surg Pathol 38:305–315CrossRef Olivia E, Egger JF, Young RH (2014) Primary endometrioid stromal sarcoma of the ovary: a clinicopathologic study of 27 cases with morphologic and behavioural features similar to those of uterine low grade endometrial stromal sarcoma. Am J Surg Pathol 38:305–315CrossRef
7.
go back to reference Husseiny GE, Bareedy NA, Mourad WA, Mohamed G, Shoukri M, Subhi J (2002) Prognostic factors and treatment modalities in uterine sarcoma. Am J Clin Oncol 25:256–260CrossRefPubMed Husseiny GE, Bareedy NA, Mourad WA, Mohamed G, Shoukri M, Subhi J (2002) Prognostic factors and treatment modalities in uterine sarcoma. Am J Clin Oncol 25:256–260CrossRefPubMed
8.
go back to reference Gadducci A, Cosio S, Romanini A, Genazzani AR (2008) The management of patients with uterine sarcomas: a debated clinical challenge. Crit Rev Oncol Haematol 65:129–142CrossRef Gadducci A, Cosio S, Romanini A, Genazzani AR (2008) The management of patients with uterine sarcomas: a debated clinical challenge. Crit Rev Oncol Haematol 65:129–142CrossRef
9.
go back to reference Feng W, Hua K, Malpica A, Zhou X, Baak JP (2013) Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough? Int J Gynecol Cancer 23(3):488–493CrossRefPubMed Feng W, Hua K, Malpica A, Zhou X, Baak JP (2013) Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough? Int J Gynecol Cancer 23(3):488–493CrossRefPubMed
Metadata
Title
Endometrial Stromal Sarcoma: Case Series with Emphasis on Gross Features
Authors
Gunjan Mangla
Preeti Diwaker
Priyanka Gogoi
Publication date
01-03-2019
Publisher
Springer India
Published in
Indian Journal of Surgical Oncology / Issue 1/2019
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-018-0847-2

Other articles of this Issue 1/2019

Indian Journal of Surgical Oncology 1/2019 Go to the issue